Castlekeep Investment Advisors LLC Invests $1 Million in Danaher Corporation $DHR

Castlekeep Investment Advisors LLC purchased a new stake in Danaher Corporation (NYSE:DHRFree Report) in the 2nd quarter, Holdings Channel.com reports. The firm purchased 5,268 shares of the conglomerate’s stock, valued at approximately $1,003,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Main Street Group LTD acquired a new position in shares of Danaher during the first quarter valued at $25,000. N.E.W. Advisory Services LLC acquired a new position in Danaher during the 2nd quarter valued at about $25,000. JPL Wealth Management LLC bought a new stake in shares of Danaher during the 3rd quarter worth about $25,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the 2nd quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the 4th quarter worth approximately $27,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

Shares of NYSE DHR opened at $215.78 on Wednesday. The business’s 50-day moving average price is $197.17 and its two-hundred day moving average price is $192.36. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a market capitalization of $151.69 billion, a P/E ratio of 38.33, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the business earned $0.77 EPS. Analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on DHR shares. TD Cowen lowered their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Wells Fargo & Company dropped their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Stifel Nicolaus dropped their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Get Our Latest Report on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.